DRW Securities’s Moderna MRNA Stock Holding History

DRW Securities’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-11,000	Closed	-$2.58M	–	337
2021 Q2	$2.58M	Buy	+11,000	New	+$1.97M	0.08%	72
2020 Q2	–	Sell	-8,000	Closed	-$240K	–	280
2020 Q1	$240K	Buy	+8,000	New	+$184K	0.01%	231

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DRW Securities's MRNA Position: Q1 2026 in Review

DRW Securities sold out of Moderna (MRNA) in Q1 2026, closing a stake of 8,442 shares — an estimated $249K sold.

DRW Securities first reported a position in MRNA in Q4 2020 and held it in 5 quarters. The position peaked at $276K in Q4 2021. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

DRW Securities reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
DRW Securities sold 8,442 Moderna shares in Q1 2026, an estimated $249K.
DRW Securities first reported a position in Moderna in Q4 2020 and held it in 5 quarters.
DRW Securities's Moderna position peaked at $276K in Q4 2021.
722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.